Xenon (XENE) Gains 7.49% on August 4

Equities Staff  |

Today Xenon Pharmaceuticals Inc (NASDAQ: XENE) is trading 7.49% up.

The latest price, as of 12:12:32 est, was $36.39. Xenon has climbed $2.52 in trading today.

296,060 shares have traded hands.

As of the previous close, Xenon has moved YTD 7.71%. The company expects its next earnings on 2022-08-11.

For technical charts, analysis, and more on Xenon visit the company profile.

About Xenon Pharmaceuticals Inc

Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.

To get more information on Xenon Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Xenon Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan
The Strong Dollar Is a Problem for Stocks

Market Movers

Sponsored Financial Content